Ignite Creation Date:
2025-12-24 @ 9:44 PM
Ignite Modification Date:
2025-12-25 @ 7:24 PM
Study NCT ID:
NCT05555732
Status:
RECRUITING
Last Update Posted:
2025-09-11
First Post:
2022-09-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)
Sponsor:
Daiichi Sankyo
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-11
Start Date Type:
ACTUAL
Primary Completion Date:
2027-08-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-08-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-09-22
First Submit QC Date:
None
Study First Post Date:
2022-09-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-09
Last Update Post Date:
2025-09-11
Last Update Post Date Type:
ESTIMATED